Invention Grant
- Patent Title: Treatment of CDKL5 disorders with GSK3β inhibitor tideglusib
-
Application No.: US16083016Application Date: 2017-03-10
-
Publication No.: US10751329B2Publication Date: 2020-08-25
- Inventor: Elisabetta Ciani , Claudia Fuchs
- Applicant: Alma Mater Studiorum—Universitá di Bologna
- Applicant Address: IT Bologna
- Assignee: Alma Mater Studiorum—Universitádi Bologna
- Current Assignee: Alma Mater Studiorum—Universitádi Bologna
- Current Assignee Address: IT Bologna
- Agency: Servilla Whitney LLC
- International Application: PCT/IB2017/000239 WO 20170310
- International Announcement: WO2017/153834 WO 20170914
- Main IPC: A61K31/433
- IPC: A61K31/433 ; A61P25/00
Abstract:
Provided herein are methods of treating a CDKL5 deficiency with tideglusib or a derivative thereof.
Public/Granted literature
- US20190091207A1 Treatment Of CDKL5 Disorders With GSK3B Inhibitor Tideglusib Public/Granted day:2019-03-28
Information query
